However, in terms of the frequency of venous thrombosis, MPL patients had a significantly higher rate than JAK2-negative patients (p = 0.02) in addition to exhibiting microvascular symptoms in MPL patients compared with other mutations (p < 0.01). This evidence concerns the gene JAK2 and Venous thrombosis.